[1]
Gutiérrez-Rojas L,Porras-Segovia A,Dunne H,Andrade-González N,Cervilla JA, Prevalence and correlates of major depressive disorder: a systematic review. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). 2020 Nov-Dec [PubMed PMID: 32756809]
[2]
Fu DJ,Ionescu DF,Li X,Lane R,Lim P,Sanacora G,Hough D,Manji H,Drevets WC,Canuso CM, Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I). The Journal of clinical psychiatry. 2020 May 12 [PubMed PMID: 32412700]
[3]
Cipriani A,Furukawa TA,Salanti G,Geddes JR,Higgins JP,Churchill R,Watanabe N,Nakagawa A,Omori IM,McGuire H,Tansella M,Barbui C, Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet (London, England). 2009 Feb 28 [PubMed PMID: 19185342]
[5]
Wong J,Motulsky A,Abrahamowicz M,Eguale T,Buckeridge DL,Tamblyn R, Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system. BMJ (Clinical research ed.). 2017 Feb 21; [PubMed PMID: 28228380]
[6]
Harmer CJ,Duman RS,Cowen PJ, How do antidepressants work? New perspectives for refining future treatment approaches. The lancet. Psychiatry. 2017 May; [PubMed PMID: 28153641]
[7]
Santarelli L,Saxe M,Gross C,Surget A,Battaglia F,Dulawa S,Weisstaub N,Lee J,Duman R,Arancio O,Belzung C,Hen R, Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (New York, N.Y.). 2003 Aug 8; [PubMed PMID: 12907793]
[8]
Sangkuhl K,Klein TE,Altman RB, Selective serotonin reuptake inhibitors pathway. Pharmacogenetics and genomics. 2009 Nov; [PubMed PMID: 19741567]
[9]
Lambert O,Bourin M, SNRIs: mechanism of action and clinical features. Expert review of neurotherapeutics. 2002 Nov; [PubMed PMID: 19810918]
[10]
Asnis GM,Henderson MA, Levomilnacipran for the treatment of major depressive disorder: a review. Neuropsychiatric disease and treatment. 2015; [PubMed PMID: 25657584]
[11]
Horst WD,Preskorn SH, Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. Journal of affective disorders. 1998 Dec; [PubMed PMID: 10333980]
[12]
Hickie IB,Rogers NL, Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet (London, England). 2011 Aug 13; [PubMed PMID: 21596429]
[13]
Gillman PK, Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. British journal of pharmacology. 2007 Jul; [PubMed PMID: 17471183]
[14]
Fiedorowicz JG,Swartz KL, The role of monoamine oxidase inhibitors in current psychiatric practice. Journal of psychiatric practice. 2004 Jul; [PubMed PMID: 15552546]
[15]
Singh JB,Fedgchin M,Daly E,Xi L,Melman C,De Bruecker G,Tadic A,Sienaert P,Wiegand F,Manji H,Drevets WC,Van Nueten L, Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. Biological psychiatry. 2016 Sep 15 [PubMed PMID: 26707087]
[16]
Castrén E,Rantamäki T, The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Developmental neurobiology. 2010 Apr [PubMed PMID: 20186711]
[17]
Kaminsky BM,Bostwick JR,Guthrie SK, Alternate Routes of Administration of Antidepressant and Antipsychotic Medications. The Annals of pharmacotherapy. 2015 Jul; [PubMed PMID: 25907529]
[19]
Denee T,Kerr C,Ming T,Wood R,Tritton T,Middleton-Dalby C,Massey O,Desai M, Current treatments used in clinical practice for major depressive disorder and treatment resistant depression in England: A retrospective database study. Journal of psychiatric research. 2021 Jul; [PubMed PMID: 34077893]
[20]
Cuijpers P,Dekker J,Hollon SD,Andersson G, Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. The Journal of clinical psychiatry. 2009 Sep; [PubMed PMID: 19818243]
[21]
Nierenberg AA,Ostacher MJ,Huffman JC,Ametrano RM,Fava M,Perlis RH, A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder. Journal of occupational and environmental medicine. 2008 Apr; [PubMed PMID: 18404015]
[22]
Beach SR,Kostis WJ,Celano CM,Januzzi JL,Ruskin JN,Noseworthy PA,Huffman JC, Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. The Journal of clinical psychiatry. 2014 May [PubMed PMID: 24922496]
[23]
Shea ML,Garfield LD,Teitelbaum S,Civitelli R,Mulsant BH,Reynolds CF 3rd,Dixon D,Doré P,Lenze EJ, Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2013 May [PubMed PMID: 23358607]
[25]
Detyniecki K, Do Psychotropic Drugs Cause Epileptic Seizures? A Review of the Available Evidence. Current topics in behavioral neurosciences. 2021 Jul 10; [PubMed PMID: 34241816]
[27]
Haria M,Fitton A,McTavish D, Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs & aging. 1994 Apr [PubMed PMID: 8019056]
[28]
Settimo L,Taylor D, Evaluating the dose-dependent mechanism of action of trazodone by estimation of occupancies for different brain neurotransmitter targets. Journal of psychopharmacology (Oxford, England). 2018 Jan [PubMed PMID: 29332554]
[29]
Ruxton K,Woodman RJ,Mangoni AA, Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis. British journal of clinical pharmacology. 2015 Aug; [PubMed PMID: 25735839]
[30]
Scotton WJ,Hill LJ,Williams AC,Barnes NM, Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International journal of tryptophan research : IJTR. 2019 [PubMed PMID: 31523132]
[31]
An D,Wei C,Wang J,Wu A, Intranasal Ketamine for Depression in Adults: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials. Frontiers in psychology. 2021; [PubMed PMID: 34140915]
[32]
Spielmans GI,Spence-Sing T,Parry P, Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified. Frontiers in psychiatry. 2020 [PubMed PMID: 32116839]
[33]
Drug interactions with selective serotonin reuptake inhibitors, especially with other psychotropics. Prescrire international. 2001 Feb; [PubMed PMID: 11503857]
[34]
Glassman AH,Bigger JT Jr, Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. Archives of general psychiatry. 1981 Jul; [PubMed PMID: 7247643]
[35]
Zwar N,Richmond R, Bupropion sustained release. A therapeutic review of Zyban. Australian family physician. 2002 May; [PubMed PMID: 12043548]
[36]
Kroenke K,Spitzer RL,Williams JB, The PHQ-9: validity of a brief depression severity measure. Journal of general internal medicine. 2001 Sep [PubMed PMID: 11556941]
[37]
Hengartner MP,Jakobsen JC,Sørensen A,Plöderl M, Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials. PloS one. 2020; [PubMed PMID: 32101579]
[38]
Hawton K,Bergen H,Simkin S,Cooper J,Waters K,Gunnell D,Kapur N, Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. The British journal of psychiatry : the journal of mental science. 2010 May; [PubMed PMID: 20435959]
[39]
White N,Litovitz T,Clancy C, Suicidal antidepressant overdoses: a comparative analysis by antidepressant type. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2008 Dec [PubMed PMID: 19031375]
[40]
Isbister GK,Bowe SJ,Dawson A,Whyte IM, Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. Journal of toxicology. Clinical toxicology. 2004 [PubMed PMID: 15362595]
[41]
Murphy L,Rasmussen J,Murphy NG, Venlafaxine overdose treated with extracorporeal life support. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2021 Feb 1; [PubMed PMID: 33526543]
[42]
Shepherd G,Velez LI,Keyes DC, Intentional bupropion overdoses. The Journal of emergency medicine. 2004 Aug [PubMed PMID: 15261357]
[43]
Beuhler MC,Spiller HA,Sasser HC, The outcome of unintentional pediatric bupropion ingestions: a NPDS database review. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2010 Mar [PubMed PMID: 20213217]
[44]
Balit CR,Lynch CN,Isbister GK, Bupropion poisoning: a case series. The Medical journal of Australia. 2003 Jan 20 [PubMed PMID: 12526723]
[45]
Kaya FB,Kuas C,Ozakin E,Karakilic ME,Kaya S, Bradyarrhythmia due to mirtazapine overdose: A case of serious adverse event in a suicidal patient. Indian journal of pharmacology. 2020 Nov-Dec; [PubMed PMID: 33666194]
[46]
Thompson JW Jr,Ware MR,Blashfield RK, Psychotropic medication and priapism: a comprehensive review. The Journal of clinical psychiatry. 1990 Oct; [PubMed PMID: 2211542]
[47]
Wen CC,Munarriz R,McAuley I,Goldstein I,Traish A,Kim N, Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside. The journal of sexual medicine. 2006 Sep [PubMed PMID: 16942536]
[48]
Das N,Kumar N, Suicidal Vilazodone Overdose Presenting as Serotonin Syndrome in a Young Woman With Major Depressive Disorder. The primary care companion for CNS disorders. 2021 Apr 29 [PubMed PMID: 34000169]
[49]
Graudins A,Stearman A,Chan B, Treatment of the serotonin syndrome with cyproheptadine. The Journal of emergency medicine. 1998 Jul-Aug [PubMed PMID: 9696181]
[51]
Gillman PK, Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British journal of anaesthesia. 2005 Oct [PubMed PMID: 16051647]
[52]
Dwight-Johnson M,Unutzer J,Sherbourne C,Tang L,Wells KB, Can quality improvement programs for depression in primary care address patient preferences for treatment? Medical care. 2001 Sep; [PubMed PMID: 11502951]
[53]
Aikens JE,Kroenke K,Swindle RW,Eckert GJ, Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. General hospital psychiatry. 2005 Jul-Aug; [PubMed PMID: 15993253]
[54]
Brown C,Battista DR,Bruehlman R,Sereika SS,Thase ME,Dunbar-Jacob J, Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Medical care. 2005 Dec; [PubMed PMID: 16299431]
[55]
Akincigil A,Bowblis JR,Levin C,Walkup JT,Jan S,Crystal S, Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Medical care. 2007 Apr; [PubMed PMID: 17496721]
[56]
Gilbody S,Bower P,Fletcher J,Richards D,Sutton AJ, Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Archives of internal medicine. 2006 Nov 27; [PubMed PMID: 17130383]